Pharos Capital Group, LLC
Pharos Capital Group, LLC
ATHEROTECH NEWS

April 28, 2010

Atherotech Offers Lifestyle Education for Heart Patients

March 15, 2010

Atherotech Recruits Top Experts in Fight Against Heart Disease

December 16, 2009

Atherotech Inc. Makes Strategic Hire for VP of Clinical Operations

August 12, 2009

Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth

July 29, 2009

Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer

May 19, 2009

Atherotech Receives Patent For ApoB Measurement

March 30, 2009

Atherotech Unveils New Cardiometabolic Test Panels

March 10, 2009

Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP® Test

February 16, 2009

VAP® Cholesterol Test Helps in Search for New Heart Disease Drugs

August 12, 2008

VAP® Cholesterol Test from Atherotech Covers an Additional 9 Million of Florida Insured

July 21, 2008

VAP® Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis

April 22, 2008

Atherotech VAP® Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients

March 25, 2008

VAP® Test Helps Researchers Uncover Best Cholesterol Lowering Treatment for Type II Diabetes

March 7, 2008

Atherotech to Exhibit The VAP® Test at ACC 2008 Meeting in Chicago

February 6, 2008

VAP® Cholesterol Test from Atherotech Covers 90 Percent of Arizona Insured

January 31, 2008

Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy

January 7, 2008

Wall Street Journal Cardiovascular Supplement: A Guide to Cardiovascular Health (pdf)

July 17, 2007

Atherotech's VAP® Test Now Includes "Clinically Superior" apoB At No Additional Cost

March 28, 2007

Atherotech Taps Healthcare Sales Veteran to Lead Sales and Marketing Team

January 31, 2007

Atherotech Announces Corporate Restructuring Initiatives

July 23, 2006

Lindora Rolls out "Know Your Numbers Season"

June 7, 2006

Atherotech Contracts with Source Scientific to Manufacture VAP® Cholesterol Test Equipment; VAP® Test Systems Will Be Available to U.S. and International Laboratories

May 31, 2006

VAP® Cholesterol Test Uncovers Hard-to-Diagnose Polycystic Ovarian Syndrome

March 8, 2006
Atherotech's VAP® Test Now Exclusive Method of Cholesterol Measurement at Lindora Medical Clinics

January 31, 2006
Atherotech Files Patent Application for Enhanced Cholesterol Test Technology

April 12, 2005
Atherotech Names Leading Cholesterol Expert Paul Ziajka as Chief Medical Officer

March 14, 2005
Atherotech's Cholesterol Test Wins Forbes Kudos

March 1, 2005
Atherotech Secures $7.5 Million in Financing from ORIX Venture Finance

October 12, 2004
Atherotech's VAP® Expanded Cholesterol Test Featured in Lindora's New Metabolic Fitness Treatment Program